Anti-Cancer Properties of Two Intravenously Administrable Curcumin Formulations as Evaluated in the 3D Patient-Derived Cancer Spheroid Model.

Int J Mol Sci · 2024 · PMC11313667 · PMID 39126111

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Regarding the number of pre-treated standard regimens, CurA showed similar outcomes in all cohort groups, while CurB showed a trend towards an increasing effect with an increasing number of pre-treated regimens.

also in 53,322 other papers

marginally significantno p-value reported

Significant results were expected at p -values < 0.05, and marginally significant results at p -values between 0.05 and 0.1.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.